CIRM Firm Against Kuehl Legislation
The Oversight Committee of the California stem cell agency Tuesday voted unanimously to oppose legislation aimed at ensuring that California shares the benefits of any therapies developed with $3 billion in state-funded research.
Reporter Terri Somers of the San Diego Union-Tribune wrote that the board considered the legislation "premature."
She quoted D…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.